Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Computerized Thermal Imaging CIO (formerly COII) -- Ignore unavailable to you. Want to Upgrade?

To: Q. who wrote (3765)	11/29/1999 10:45:00 PM
From: Q.	Read Replies (1) \| Respond to of 6039

"the AMA passed a resolution stating that the thermography had not been proven to have value as a medical diagnostic test." that's an excerpt from the risk-factor section of a 10k from HMSC, filed 9 months before HMSC ceased operations. Here's more from the same filing: In 1983, OHTA issued a report stating that thermography needed further development and should not be used alone for diagnostic screening for breast cancer. In 1984, HCFA withdrew coverage for thermography under Medicare as a diagnostic screening method for breast disease. In 1991, based upon reports which addressed the use of thermography in neurological and musculoskeletal conditions, the AMA passed a resolution stating that the thermography had not been proven to have value as a medical diagnostic test. In 1992, HCFA withdrew Medicare reimbursement for all other uses of thermography. In 1993, the AMA adopted a resolution stating that use of hermography for diagnostic purposes could not be recommended at that time. edgar-online.com